Compare · DXCM vs WOK
DXCM vs WOK
Side-by-side comparison of DexCom Inc. (DXCM) and WORK Medical Technology Group LTD (WOK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and WOK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $30.35B, about 5435.2x WOK ($5.6M).
- DXCM has been more active in the news (14 items in the past 4 weeks vs 1 for WOK).
- DXCM has more recent analyst coverage (25 ratings vs 0 for WOK).
- Company
- DexCom Inc.
- WORK Medical Technology Group LTD
- Price
- $81.39+1.29%
- -
- Market cap
- $30.35B
- $5.6M
- 1M return
- -2.52%
- -
- 1Y return
- +36.31%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- 2024
- News (4w)
- 14
- 1
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Latest DXCM
- EVP Chief Legal Compliance Off Brown Michael Jon covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 96,734 units (SEC Form 4) to cover withholding tax
- EVP, COO & CFO Sylvain Jereme M covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.99% to 145,377 units (SEC Form 4) (for tax liability)
- EVP Chief People & Culture Off Stern Sadie covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 119,462 units (SEC Form 4) to satisfy withholding obligation
- President, CEO, and Director Leach Jacob Steven covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.35% to 417,457 units (SEC Form 4) to satisfy withholding tax
- Dexcom Announces Upcoming Conference Presentation
- SEC Form SCHEDULE 13G filed by DexCom Inc.
- Director Ashley Euan A. gifted 2,389 shares (SEC Form 4)
- Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign
- SEC Form 10-Q filed by DexCom Inc.
- SEC Form 8-K filed by DexCom Inc.
Latest WOK
- SEC Form 6-K filed by WORK Medical Technology Group LTD
- SEC Form 6-K filed by WORK Medical Technology Group LTD
- SEC Form 6-K filed by WORK Medical Technology Group LTD
- Large owner Hrt Financial Lp bought $40,501 worth of shares (880,456 units at $0.05) and sold $528,894 worth of shares (136,665 units at $3.87), decreasing direct ownership by 68% to 123,944 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $25,548 worth of shares (268,927 units at $0.10) and sold $168,465 worth of shares (2,904,567 units at $0.06), decreasing direct ownership by 87% to 391,456 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $3,849 worth of shares (48,108 units at $0.08), increasing direct ownership by 2% to 3,027,096 units (SEC Form 4)
- WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
- Large owner Hrt Financial Lp bought $363,500 worth of shares (3,794,711 units at $0.10) (SEC Form 4)
- New insider Hrt Financial Lp claimed ownership of 949,661 shares (SEC Form 3)
- Large owner Hrt Financial Lp sold $363,617 worth of shares (3,463,022 units at $0.10), closing all direct ownership in the company (SEC Form 4)